Evidence map›Paper›PMID 25147656›Full record

ArticleJundishapur journal of microbiology2014

Morphological and Bactericidal Effects of Different Antibiotics on Helicobacter pylori.

Jamshid Faghri, Farkhondeh Poursina, Sharareh Moghim, Hamid Zarkesh Esfahani, Bahram Nasr Esfahani, Hossein Fazeli, Nasrin Mirzaei, Azam Jamshidian, Hajieh Ghasemian Safaei

Open access · hybridAbstract read
In one paragraph

Article in Jundishapur journal of microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. Optimized high-dose amoxicillin-proton-pump inhibitor dual therapies fail to achieve high cure rates in China.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
    Trial
  3. Article
  4. Characterization ofFrontiers in microbiology · 2026
    Article
  5. Determination of GenesThe Yale journal of biology and medicine · 2025
    Article
  6. CoccoidVirulence · 2025
    Review
  7. Molecular Mechanisms of Biofilm Formation inAntibiotics (Basel, Switzerland) · 2024
    Review
  8. Article
  9. International journal of molecular sciences · 2023
    Article
  10. Article
  11. A study on the diagnosis of theFrontiers in microbiology · 2022
    Article
  12. Research progress in theZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The Puzzle of Coccoid Forms ofAntibiotics (Basel, Switzerland) · 2020
    Review
  18. Transformation ofPathogens (Basel, Switzerland) · 2020
    Review
  19. Clinical and laboratory importance of detectingPrzeglad gastroenterologiczny · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jamshid FaghriDepartment of Microbiology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IR Iran.
Farkhondeh PoursinaDepartment of Microbiology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IR Iran.
Sharareh MoghimDepartment of Microbiology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IR Iran.
Hamid Zarkesh EsfahaniDepartment of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IR Iran.
Bahram Nasr EsfahaniDepartment of Microbiology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IR Iran.
Hossein FazeliDepartment of Microbiology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IR Iran.
Nasrin MirzaeiDepartment of Biology, Islamic Azad University, Tonekabon branch, Tonekabon, IR Iran.
Azam JamshidianDepartment of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IR Iran.
Hajieh Ghasemian SafaeiDepartment of Microbiology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IR Iran.
Isfahan University of Medical Sciences · IRIslamic Azad University Tonekabon · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHelicobacter pylori (H. pylori) is a spiral Gram negative bacteria that can transform to the coccoid form in adverse conditions.

objectivesThe aim of this study was to determine the in vitro morphological and bactericidal effects of metronidazole, amoxicillin and clarithromycin on H. pylori. MATERIALS AND

methodsThe standard strain 26695 of H. pylori was cultured on Brucella agar (BA) and the minimum inhibitory concentrations (MICs) of three antibiotics were determined by E-test method. The bacteria were exposed to antibiotics at 1/2 MIC, MIC and 2X MIC concentrations in Brucella broth (BB). Induced coccoid forms were confirmed by Gram staining and light microscopy. The viability of cells as well as the susceptibility of viable coccoids to antibiotics were examined using the flow cytometry method.

resultsAll of the three antibiotics at sub-MIC induced coccoid forms. The highest rates of coccoids (> 90%) were induced at 0.008 μg/mL concentration (1/2 MIC) of amoxicillin, 72 hours postexposure. Metronidazole and clarithromycin with 1/2 MIC (0.5 and 0.125 µg/mL respectively) induced lower rates of coccoid forms (60% and 40% respectively). Potent bactericidal effects on coccoids were observed with Metronidazole at 2X MIC and clarithromycin at MIC (0.25 µg/mL) (80 - 90%). Amoxicillin with MIC and 2X MIC had no bactericidal effect on coccoid forms.

conclusionsDespite the good in vitro bactericidal effect of amoxicillin on spiral forms of H. pylori, this antibiotic has little effect on induced coccoids that may develop after the inappropriate in vivo antibacterial treatment. Hence, for successful therapy, it is essential not only to eradicate the spiral forms, but to eliminate the viable coccoids.

Indexed as

AntibioticsCoccoid BacteriaHelicobacter pyloriSusceptibility

Identifiers

PMID25147656
PMCPMC4138673
OpenAlexW2158121593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.